DE2547224A1 - Organische verbindungen, ihre verwendung und herstellung - Google Patents

Organische verbindungen, ihre verwendung und herstellung

Info

Publication number
DE2547224A1
DE2547224A1 DE19752547224 DE2547224A DE2547224A1 DE 2547224 A1 DE2547224 A1 DE 2547224A1 DE 19752547224 DE19752547224 DE 19752547224 DE 2547224 A DE2547224 A DE 2547224A DE 2547224 A1 DE2547224 A1 DE 2547224A1
Authority
DE
Germany
Prior art keywords
coli
enterotoxin
labile
heat
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752547224
Other languages
German (de)
English (en)
Inventor
Friedrich Dorner
Georg Laber
Peter Mayer
Eberhard Schuetze
Rudolf Weil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1467174A external-priority patent/CH612994A5/de
Priority claimed from CH604075A external-priority patent/CH615196A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of DE2547224A1 publication Critical patent/DE2547224A1/de
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19752547224 1974-11-01 1975-10-22 Organische verbindungen, ihre verwendung und herstellung Ceased DE2547224A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1467174A CH612994A5 (en) 1974-11-01 1974-11-01 Process for the preparation of coli enterotoxin
CH1645874 1974-12-11
CH1645974 1974-12-11
CH604075A CH615196A5 (en) 1975-05-12 1975-05-12 Purification process for coli enterotoxin

Publications (1)

Publication Number Publication Date
DE2547224A1 true DE2547224A1 (de) 1976-05-13

Family

ID=27428963

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752547224 Ceased DE2547224A1 (de) 1974-11-01 1975-10-22 Organische verbindungen, ihre verwendung und herstellung

Country Status (16)

Country Link
JP (1) JPS5170810A (enrdf_load_stackoverflow)
AU (1) AU511934B2 (enrdf_load_stackoverflow)
CA (1) CA1053152A (enrdf_load_stackoverflow)
DD (1) DD124879A5 (enrdf_load_stackoverflow)
DE (1) DE2547224A1 (enrdf_load_stackoverflow)
DK (2) DK478575A (enrdf_load_stackoverflow)
ES (1) ES442242A1 (enrdf_load_stackoverflow)
FI (2) FI752964A7 (enrdf_load_stackoverflow)
FR (1) FR2289206A1 (enrdf_load_stackoverflow)
GB (1) GB1529871A (enrdf_load_stackoverflow)
IE (1) IE43702B1 (enrdf_load_stackoverflow)
IL (1) IL48384A (enrdf_load_stackoverflow)
NL (1) NL7512590A (enrdf_load_stackoverflow)
NO (1) NO753578L (enrdf_load_stackoverflow)
NZ (1) NZ179108A (enrdf_load_stackoverflow)
SE (1) SE8100404L (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738364B (en) * 1972-12-04 1974-09-25 Rit Rech Ind Therapeut Piglet colibacillosis vaccines and process for their preparation

Also Published As

Publication number Publication date
SE8100404L (sv) 1981-01-23
DK478575A (da) 1976-05-02
IL48384A (en) 1979-05-31
DD124879A5 (enrdf_load_stackoverflow) 1977-03-16
NZ179108A (en) 1978-07-28
DK278478A (da) 1978-06-20
AU8628275A (en) 1977-05-12
CA1053152A (en) 1979-04-24
NL7512590A (en) 1976-05-04
IL48384A0 (en) 1976-03-31
NO753578L (enrdf_load_stackoverflow) 1976-05-04
IE43702B1 (en) 1981-05-06
FR2289206A1 (fr) 1976-05-28
IE43702L (en) 1976-05-01
ES442242A1 (es) 1977-08-01
FI752964A7 (enrdf_load_stackoverflow) 1976-05-02
FR2289206B1 (enrdf_load_stackoverflow) 1978-11-10
AU511934B2 (en) 1980-09-11
JPS5170810A (enrdf_load_stackoverflow) 1976-06-18
GB1529871A (en) 1978-10-25
FI782827A7 (fi) 1978-09-14

Similar Documents

Publication Publication Date Title
DE69032806T2 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
DE69534992T2 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
DE69618018T2 (de) Arzneimittel enthaltend botulinum toxin oder neurotoxin und herstellungsverfahren
DE68928432T2 (de) Legionellosis-impfstoffe und verfahren zur herstellung
DE69127694T2 (de) Herstellung und verwendung von transfer-faktor
DE69016129T2 (de) Vakzin gegen Escherichia coli.
DE69527986T2 (de) Antigene arznei zur behandlung oder vorbeugung
DE69232969T2 (de) Methode zur herstellung von gram-negativen bakteriellen vakzinen
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE69922990T2 (de) Herstellungsverfahren von festphasekonjugateimpfstoffen
EP0173241B1 (de) Vakzine zur Behandlung der Harnwegsinfektionen
DE69731891T2 (de) Verfahren zur reinigung von gbs-toxin/cm101
DE69014543T2 (de) Multivalentes immunogen lmi.
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
DE68926427T2 (de) Vom streptococcus m-protein abgeleitete synthetische peptide und damit hergestellte impfstoffe
DE68916424T2 (de) Pasteurella-impfstoff.
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
WO1988008032A1 (en) Receptor from the small rhinovirus receptor group
DE69025375T2 (de) Verfahren
DE2547224A1 (de) Organische verbindungen, ihre verwendung und herstellung
DE68917709T2 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
AT364452B (de) 10rfahren zur reinigung und isolierung von e.colienterotoxin
DE2845745C2 (enrdf_load_stackoverflow)
EP0491125B2 (de) Impfstoffe gegen equine Herpesviren
DE19821859A1 (de) Darstellung immunogener (Kapsel-)Polysaccharid-Konjugate durch orientierte Kupplung synthetischer T-Zell-Epitope zur Erzeugung von Vakzinen gegen N.meningitidis

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection